Ensign Peak Advisors
BPMC

Ensign Peak Advisors’s Blueprint Medicines BPMC Stock Holding History

Ensign Peak Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,500
Closed -$4.17M – 1701
2025
Q2 		$4.17M Sell
32,500
-271,232
-89% -$28.2M 0.01% 684
2025
Q1 		$26.9M Buy
303,732
+28,308
+10% +$2.76M 0.05% 259
2024
Q4 		$24M Sell
275,424
-50,722
-16% -$4.65M 0.04% 289
2024
Q3 		$30.2M Buy
326,146
+19,830
+6% +$1.97M 0.05% 253
2024
Q2 		$33M Sell
306,316
-13,212
-4% -$1.32M 0.06% 225
2024
Q1 		$30.3M Buy
319,528
+94,404
+42% +$8.1M 0.06% 250
2023
Q4 		$20.8M Buy
225,124
+196,984
+700% +$12.8M 0.04% 293
2023
Q3 		$1.41M Hold
28,140
– – ﹤0.01% 961
2023
Q2 		$1.78M Hold
28,140
– – ﹤0.01% 923
2023
Q1 		$1.27M Buy
28,140
+1,600
+6% +$72.1K ﹤0.01% 1062
2022
Q4 		$1.16M Buy
26,540
+11,500
+76% +$551K ﹤0.01% 1047
2022
Q3 		$991K Sell
15,040
-48,158
-76% -$3.09M ﹤0.01% 1069
2022
Q2 		$3.19M Sell
63,198
-7,426
-11% -$435K 0.01% 647
2022
Q1 		$4.51M Buy
70,624
+2,810
+4% +$202K 0.01% 619
2021
Q4 		$7.26M Buy
67,814
+20,368
+43% +$2.13M 0.01% 555
2021
Q3 		$4.88M Buy
47,446
+16,953
+56% +$1.58M 0.01% 670
2021
Q2 		$2.68M Buy
30,493
+1,000
+3% +$91.6K 0.01% 954
2021
Q1 		$2.87M Buy
29,493
+7,769
+36% +$776K 0.01% 894
2020
Q4 		$2.44M Buy
21,724
+2,925
+16% +$308K 0.01% 952
2020
Q3 		$1.74M Sell
18,799
-974
-5% -$75K ﹤0.01% 1042
2020
Q2 		$1.54M Sell
19,773
-2,417
-11% -$163K ﹤0.01% 1101
2020
Q1 		$1.3M Sell
22,190
-636
-3% -$40.9K ﹤0.01% 1052
2019
Q4 		$1.83M Buy
+22,826
New +$1.71M ﹤0.01% 1096

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ensign Peak Advisors's BPMC Position: Q3 2025 in Review

Ensign Peak Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 32,500 shares — an estimated $4.17M sold.

Ensign Peak Advisors first reported a position in BPMC in Q4 2019 and held it in 23 quarters. The position peaked at $33M in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Ensign Peak Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 32,500 Blueprint Medicines shares in Q3 2025, an estimated $4.17M.
  • Ensign Peak Advisors first reported a position in Blueprint Medicines in Q4 2019 and held it in 23 quarters.
  • Ensign Peak Advisors's Blueprint Medicines position peaked at $33M in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Ensign Peak Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.